Atossa Therapeutics Inc.

NASDAQ: ATOS
Share price (1/8/25): $0.92
Market cap (1/8/25): $116 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Delaying amendment

Shelf registration

Shelf registration

Registration of securities for employees

Ownership Filter

Vanguard Group Inc

Vanguard Group Inc

News Filter

To Present Pharmacokinetic and Tolerability Data From Phase 2 EVANGELINE Trial at the 2024 San Antonio Breast Cancer Symposium

Material Definitive Agreement

Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Reports Positive KARISMA-Endoxifen Trial Results: (Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies

Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission